Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Genetic Tech Spn ADR
(NQ:
GENE
)
2.221
+0.041 (+1.88%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Genetic Tech Spn ADR
< Previous
1
2
Next >
Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering
April 22, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Genetic Technologies Announces $2 Million Registered Direct Offering
April 18, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes
April 17, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year
April 16, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
April 12, 2024
Via
ACCESSWIRE
GTG to pilot GeneType in Breast Screen centers across the U.S.
April 11, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
EVENT - Empowering Women Through Knowledge; Humanise Health & GeneType Launch "Know Your Risk”
April 08, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Genetic Technologies’ Digital Strategy Ignites Significant Traction in US Market
April 02, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
GTG Global Collaborations and Innovation Update
March 26, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised Healthcare
March 25, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
GTG to launch U.S. Customer Digital Media Sales Campaign
February 28, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Launching our most comprehensive test and expanding into new global markets
January 31, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement
January 05, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
December 29, 2023
Via
ACCESSWIRE
GeneType's Groundbreaking Saliva Test Transforms Early Disease Detection, Paving the Way for Personalized Wellness
December 14, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change
December 12, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Gene Business Update: Private Hospital Partnership; Expanded Multi-Test for Australian Market and Commercial Partner for Cancer Clinical Trial
October 30, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
GeneType Predicting Risk of Pancreatic Cancer: Major Breakthrough in Early Detection and Treatment
October 18, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Knightscope, Soligenix, and Genetic Technologies Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
October 06, 2023
Via
ACCESSWIRE
Genetic Technologies building pathway to profitability
September 27, 2023
Genetic Technologies Ltd (ASX:GTG; NASDAQ:GENE) CEO Simon Morriss tells Proactive the focus over the next 18 years is putting the pathway in place to see the business on track to profitability. GTG...
Via
TheNewswire.com
GTG Signs Precision Medicine Pilot with Australia’s Largest Private Hospital Network
September 27, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Aridis Pharmaceuticals, Inc., Genetic Technologies Limited, and American Resources Corporation Interviews to Air on the RedChip Money Report® on Bloomberg TV
September 15, 2023
Via
ACCESSWIRE
Breakthrough: GeneType for Pancreatic Cancer, Melanoma, and Atrial Fibrillation Cleared for Australian Release
September 12, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
GENE Positioned at the Forefront of Multi-cancer Clinical Utility Research - MRFF Grant names GTG as sole Industry Partner
September 11, 2023
Trial to Assess Multi Cancer Genetic Risk Assessment in General Practice
From
Genetic Technologies Ltd
Via
GlobeNewswire
Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report® on Bloomberg TV
September 01, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report(R) on Bloomberg TV
September 01, 2023
Via
ACCESSWIRE
Annual Results – Momentum Building on our Commercial Plans
August 30, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Genetic Technologies Limited Announces Updated Investor Presentation
August 09, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Quarterly Activities Update: Encouraging Growth for geneType Commercial Test Volume
July 28, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Genetic Technologies Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
July 21, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.